Sandu Pharmaceuticals Ltd — Important, 07-02-2026: Company Update

Sandu Pharmaceuticals has announced its financial results for the quarter and nine-month period. Quarterly revenue stood at 18.77 Cr, with a net profit of 0.98 Cr. For the nine-month period, total income reached 53.16 Cr and net profit was 1.72 Cr. Earnings per share for the quarter were Rs 1.01. Separately, the company announced a special window enabling shareholders to dematerialize physical shares. These transferred securities will be subject to a one-year lock-in, during which they cannot be traded or pledged, facilitating conversion to electronic format for easier management.